SCHEMBL9924256

SCHEMBL9924256

CCOC(=O)NC1CCC(N/C(=N\C(=O)c2cccc(C)c2)Nc2cc(F)cc(Cl)c2)CC1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CTDSP1 Q9GZU7 2/20 0.36
LMNA P02545 1/20 0.36
GLA P06280 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CHRM3 P20309 3/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
SLC6A9 P48067 1/20 0.35
SLC6A5 Q9Y345 1/20 0.35
DRD2 P14416 1/20 0.35
CYP2D6 P10635 1/20 0.34
GRM4 Q14833 1/20 0.34
EPHX2 P34913 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9924077 0.92 GRM4 (0.38) LMNAHSD17B10CHRM3KMT2ASLC6A9
SCHEMBL9924331 0.91 NPC1 (0.40) NPC1RAB9ALMNAHSD17B10MEN1
SCHEMBL9924255 0.90 GRM4 (0.36) CHRM3MEN1KMT2ASLC6A9SLC6A5
SCHEMBL9924228 0.90 CHRM1 (0.38) MEN1KMT2ADRD2GRM4EPHX2
SCHEMBL9924259 0.90 CHRM1 (0.38) MEN1KMT2ADRD2GRM4EPHX2
SCHEMBL17206702 0.90 CHRM1 (0.38) MEN1KMT2ADRD2GRM4EPHX2
SCHEMBL9924087 0.89 HSD11B1 (0.39) LMNAMEN1KMT2AL3MBTL1SLC6A9
SCHEMBL9924084 0.89 GRM4 (0.35) LMNACHRM3MEN1KMT2ATDP1
SCHEMBL9924254 0.88 CHRM1 (0.39) CHRM3MEN1KMT2AGRM4EPHX2
SCHEMBL9924329 0.86 SLC6A9 (0.40) LMNAKMT2AL3MBTL1SLC6A9EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
WO-2012078867-A2 CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed